Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

BACKGROUND: Despite its high prevalence and clinical significance, clinical measurement of lipoprotein(a) is rare but has not been systematically quantified. We assessed the prevalence of lipoprotein(a) testing overall, in those with various cardiovascular disease (CVD) conditions and in those under...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatia, Harpreet S., Hurst, Samantha, Desai, Paresh, Zhu, Wenhong, Yeang, Calvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547299/
https://www.ncbi.nlm.nih.gov/pubmed/37702041
http://dx.doi.org/10.1161/JAHA.123.031255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547299/
https://www.ncbi.nlm.nih.gov/pubmed/37702041
http://dx.doi.org/10.1161/JAHA.123.031255

Ejemplares similares